Back

Nicox’s NCX 470 China application accepted for review

Verifying
  • Nicox said Ocumension’s NCX 470 application was accepted for review in China.
  • China’s NMPA accepted the application on September 10, 2026, after its August submission.
  • NCX 470 has completed the positive Mont Blanc and Denali Phase 3 trials.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.